Literature DB >> 17372673

Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice.

O Nakagawasai1, A Murata, Y Arai, A Ohba, K Wakui, S Mitazaki, F Niijima, K Tan-No, T Tadano.   

Abstract

While many studies suggest an involvement of brain serotonergic systems in neuro-psychiatric disorders such as schizophrenia and depression, their role in Wernicke-Korsakoff syndrome (WKS) remains unclear. Since dietary thiamine deficiency (TD) in mice is considered as a putative model of WKS, it was used in the present study to investigate the function of serotonergic neurons in this disorder. After 20 days of TD feeding, the intensity of tryptophan hydroxylase immunofluorescence was found to be significantly decreased in the dorsal and medial raphe nuclei. In addition, the head-twitch response (HTR) elicited by the intracerebroventricular administration of the 5-HT(2A) agonist 2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI) was significantly increased in TD versus control mice, whereas the injection of ketanserin, a 5-HT(2A) receptor antagonist, prevented this enhancement. A single injection of thiamine HCl on the 19th day of TD feeding did not reduce the enhanced DOI-induced HTR. On the other hand, the administration of d-fenfluramine, a 5-HT releaser, did not enhance the HTR in TD mice. Together, our results indicate that TD causes a super-sensitivity of 5-HT(2A) receptors by reducing presynaptic 5-HT synthesis derived from degenerating neurons projecting from the raphe nucleus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372673     DOI: 10.1007/s00702-007-0655-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  55 in total

1.  Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.

Authors:  T Nabeshima; K Yamaguchi; K Ishikawa; H Furukawa; T Kameyama
Journal:  J Pharmacol Exp Ther       Date:  1987-12       Impact factor: 4.030

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Effects of dexfenfluramine or 5,7-dihydroxytryptamine on tryptophan hydroxylase and serotonin transporter mRNAS in rat dorsal raphe.

Authors:  S L Semple-Rowland; A Mahatme; N E Rowland
Journal:  Brain Res Mol Brain Res       Date:  1996-09-05

4.  Characteristics of muricide induced by thiamine deficiency and its suppression by antidepressants or intraventricular serotonin.

Authors:  K Onodera; Y Ogura; K Kisara
Journal:  Physiol Behav       Date:  1981-11

5.  Screening hallucinogenic drugs: systematic study of three behavioral tests.

Authors:  M T Silva; H M Calil
Journal:  Psychopharmacologia       Date:  1975-05-28

6.  Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.

Authors:  T Tadano; S Satoh; N Satoh; K Kisara; Y Arai; S K Kim; H Kinemuchi
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

7.  Changes in serotonergic neurons in the brain of pyrithiamine-induced acute thiamine-deficient mice.

Authors:  H Matsushita; Y Takeuchi; K Kosaka; S Fushiki; M Kawata; T Sawada
Journal:  Acta Neuropathol       Date:  1999-12       Impact factor: 17.088

8.  The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs.

Authors:  T Yamamoto; S Ueki
Journal:  Pharmacol Biochem Behav       Date:  1981-01       Impact factor: 3.533

9.  Intracerebroventricular administration of 5,7-dihydroxytryptamine to mice increases both head-twitch response and the number of cortical 5-HT2 receptors.

Authors:  D J Heal; J Philpot; S G Molyneux; A Metz
Journal:  Neuropharmacology       Date:  1985-12       Impact factor: 5.250

10.  Enhancement of 5-hydroxytryptamine-induced head-twitch response after olfactory bulbectomy.

Authors:  O Nakagawasai; T Tadano; Y Arai; S Hozumi; A Oba; K Tan-No; H Yasuhara; K Kisara; L Oreland
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  5 in total

Review 1.  Brain and behavioral pathology in an animal model of Wernicke's encephalopathy and Wernicke-Korsakoff Syndrome.

Authors:  Ryan P Vetreno; Raddy L Ramos; Steven Anzalone; Lisa M Savage
Journal:  Brain Res       Date:  2011-11-28       Impact factor: 3.252

Review 2.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

3.  Postpartum depression: psychoneuroimmunological underpinnings and treatment.

Authors:  George Anderson; Michael Maes
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-21       Impact factor: 2.570

Review 4.  Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.

Authors:  Natalie M Zahr; Adolf Pfefferbaum
Journal:  Alcohol Res       Date:  2017

5.  Fully automated head-twitch detection system for the study of 5-HT2A receptor pharmacology in vivo.

Authors:  Mario de la Fuente Revenga; Jong M Shin; Hiba Z Vohra; Kelsey S Hideshima; Matthew Schneck; Justin L Poklis; Javier González-Maeso
Journal:  Sci Rep       Date:  2019-10-03       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.